Emerging evidence suggests that FGF19 may also participate in the regulation of ovarian function through the paracrine or endocrine pathways, demonstrating a potential association with PCOS (Zhu et al., 2023; Ramanjaneya et al., 2020). Here, FGF19 is linked to polycystic ovary syndrome.